Natural health product · NPN 80072535
Cortisolv
Yes: licensed in Canada
The product licence is active. Whether the product is actually on the market is a separate, voluntary notice; the official record shows it.
Licence status Active; licensed September 14, 2016; licence last revised June 12, 2017.
- Natural Product Number (NPN)
- 80072535
- Licence holder
- Xymogen
- Dosage form
- Capsule
- Route
- Oral
- Licensing route
- Non-Traditional
- First licensed
- September 14, 2016
- Licence last revised
- June 12, 2017
Medicinal ingredients
Per dosage unit, as licensed.
| Ingredient | Amount | Source and potency |
|---|---|---|
| Phellodendron amurense | 22.5 milligrams | Bark; 2.5 % berberine |
| Magnolia officinalis | 68.75 milligrams | Bark; 8.5 % honokiol |
| L-Theanine | 100 milligrams | |
| Lagerstroemia speciosa | 48 milligrams | Leaf; 1 % Corosolic acid |
| Withania somnifera | 150 milligrams | Leaf; 32 % Withania oligosaccharides |
| Withania somnifera | — | Leaf; 10 % withanolides |
| Withania somnifera | 150 milligrams | Root; 32 % Withania oligosaccharides |
| Withania somnifera | — | Root; 10 % withanolides |
| Rhaponticum carthamoides | 50 milligrams | Root |
What it is licensed for
The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.
- Supports healthy cortisol levels, a biomarker of stress. Temporarily relieves symptoms of perceived stress. Helps reduce the symptoms of stress, such as fatigue, sleeplessness, irritability, and inability to concentrate.
Non-medicinal ingredients
Hypromellose; Pregelatinized starch; Medium chain triglycerides; Corn starch; Silica; L-leucine; Ascorbyl Palmitate; Microcrystalline cellulose